Tagged With Pharmaceuticals

Wall Street thinks CBD could be a $16 billion industry by 2025. Here's what the cannabis compound does to your brain and body.


A UK drugmaker's stock crashed 80% after it was indicted for a 'truly shameful' opioid-addiction scheme


Big pharma's big bets, a hedge-fund rivalry, and Silicon Valley's obsession with failing forward



Bayer plunges after jury finds its Roundup weedkiller caused cancer


Scientists just made marijuana compounds in a lab for the first time, and it could open the door to new treatments for devastating diseases


Colorado became the first state to cap the monthly cost of insulin at $100. Here's why the life-saving drug is so expensive.



America's top pharma CEOs just got grilled by Congress over the cost of their drugs


A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval


Meet the Sacklers, one of the richest families in America, who built their $14 billion fortune off of controversial prescription drug OxyContin


Walmart and CVS just resolved their $4 billion dispute over where you can pick up your prescriptions


A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly


Trump may have shamed Pfizer for increasing drug prices, but that isn't stopping drugmakers from doing more of the same



A smiley-face text message about hiking the price of an old drug is at the center of a massive lawsuit being brought against nearly 20 big drug companies


GlaxoSmithKline will be broken up in a megadeal with Pfizer that could change the face of global healthcare


A treatment for the most common food allergy could be available next year, and one biotech just drew ahead in the race for the $3 billion market


A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure



The world's biggest fund managers are dumping tech to an extent not seen since the financial crisis — here's what they're scooping up instead


Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.


A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect


A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it's eyeing the pharma industry